Zobrazeno 1 - 10
of 74
pro vyhledávání: '"D. H. St Pierre"'
Publikováno v:
Obésité. 11:227-235
L’obesite est un facteur de risque majeur de morbidite et de mortalite chez l’humain. Plusieurs dysfonctions collaterales telles que les troubles cardiovasculaires et musculosquelettiques, le diabete de type 2, la steatose hepatique ainsi que cer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1709d3107817ee83ad9f62c83042acd4
https://doi.org/10.1007/s11690-016-0542-9
https://doi.org/10.1007/s11690-016-0542-9
Autor:
L, Magri-Tomaz, L, Melbouci, J, Mercier, Ya, Ou, N, Auclair, F S, Lira, J-M, Lavoie, D H, St-Pierre
Publikováno v:
Cell biochemistry and function. 36(7)
Metabolic disorders are often associated with liver steatosis and increased plasma cholesterol levels. However, the link between excessive lipid accumulation and impairments in cholesterol metabolism remains uninvestigated in the liver. Short term of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f701298431c23ffc8d9831554d336e3
https://pubmed.ncbi.nlm.nih.gov/30284312
https://pubmed.ncbi.nlm.nih.gov/30284312
Autor:
Miriam Goebel-Stengel, Andreas Stengel, Niall P. Murphy, N. T. Maidment, Yvette Taché, Lixin Wang, D. H. St Pierre
Publikováno v:
Neurogastroenterology & Motility. 24:e235-e245
Background Levodopa (l-dopa) is the most commonly used treatment for alleviating symptoms of Parkinson’s disease. However, l-dopa delays gastric emptying, which dampens its absorption. We investigated whether ghrelin prevents l-dopa action on gastr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c41ba29ba5aada3db5b4a1e8c3ca24
https://doi.org/10.1111/j.1365-2982.2012.01904.x
https://doi.org/10.1111/j.1365-2982.2012.01904.x
Autor:
Andrea Benso, V. Ramella-Gigliardi, Flavia Prodam, Fabio Broglio, Barbara Lucatello, Ilaria Olivetti, M. Tomelini, Elena Gramaglia, D. H. St-Pierre
Publikováno v:
Journal of Endocrinological Investigation. 33:363-367
It is well recognized that beta-adrenergic receptors mediate important endocrine and metabolic actions. In fact, beta-adrenergic receptor activation negatively influences GH secretion while exerting relevant metabolic actions such as the stimulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b5e241555d3d0f724fdfabfad3143b9
https://doi.org/10.1007/bf03346604
https://doi.org/10.1007/bf03346604
Autor:
D. H. St-Pierre, Fabio Broglio, A. Dotta, Elisa Calvi, M. Tomelini, Sara Belcastro, Ezio Ghigo, Ilaria Olivetti, Andrea Benso, Elena Gramaglia
Publikováno v:
Endocrine. 48(3)
The aim of this study is to describe a potential modulatory effect of acute acylated ghrelin (AG) administration on the glucose, insulin, and free fatty acids (FFA) responses to salbutamol (SALBU). Six healthy young male volunteers underwent the foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d7be2d1b6eeca42d70684f46e80222
https://pubmed.ncbi.nlm.nih.gov/25012253
https://pubmed.ncbi.nlm.nih.gov/25012253
Autor:
V. Ramella Gigliardi, Fabio Broglio, Ilaria Olivetti, D H St Pierre, Andrea Benso, M. Tomelini, Sara Belcastro, S Frara, Ezio Ghigo, Elena Gramaglia, Elisa Calvi
Publikováno v:
European journal of endocrinology. 168(4)
ObjectiveGH secretion is regulated by an interplay between GH-releasing hormone (GHRH), somatostatin (SST), and other central and peripheral signals. Acylated ghrelin (AG) amplifies GH pulsatility acting, at least partially, independently from GHRH a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222c61cd3aa209898dd721b06f0371bb
https://pubmed.ncbi.nlm.nih.gov/23295542
https://pubmed.ncbi.nlm.nih.gov/23295542
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 24(5)
Levodopa (L-dopa) is the most commonly used treatment for alleviating symptoms of Parkinson's disease. However, L-dopa delays gastric emptying, which dampens its absorption. We investigated whether ghrelin prevents L-dopa action on gastric emptying a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6a1dc759f53e49531d795f4f2a1c00b3
https://pubmed.ncbi.nlm.nih.gov/22443313
https://pubmed.ncbi.nlm.nih.gov/22443313
Autor:
F. Broglio, D. H. St-Pierre
Metabolic pathologies such as Type 2 Diabetes have become a major health problem for worldwide populations. Unfortunately, efforts to cure and especially to prevent these significant global problems have so far been met with disappointment. Recently,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2783781ad3c258f1a87191bdccae705
http://hdl.handle.net/2318/122376
http://hdl.handle.net/2318/122376
Autor:
Andrea Benso, Fabio Broglio, V. Ramella Gigliardi, D H St Pierre, Elena Gramaglia, Fabrizio Riganti, Flavia Prodam, Ilaria Olivetti, Barbara Lucatello, Ezio Ghigo
Publikováno v:
Clinical endocrinology. 71(2)
Summary Background Acylated ghrelin (AG) is a physiological GH secretion amplifier, in part stimulating GHRH neurones and antagonizing somatostatin activity. In humans, AG is one of the most potent pharmacological stimuli of GH secretion and, unlike
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56dfb51c209781ebdb7493b17b1300a0
https://pubmed.ncbi.nlm.nih.gov/19067721
https://pubmed.ncbi.nlm.nih.gov/19067721
Autor:
Bredsdorff, Lea1 contam@efsa.europa.eu, Olesen, Pelle Thonning1, Beltoft, Vibe Meister1, Sharma, Anoop Kumar1, Hansen, Max1, Nørby, Karin1, Ravn‐Haren, Gitte1, Ekstrøm, Jeannette1
Publikováno v:
EFSA Supporting Publications. Apr2023, Vol. 20 Issue 4, p1-201. 201p.